Panuveitis

Download PDF

Recent Publications on Panuveitis:
Visual Prognosis and Risk Factors for Korean Patients with Behcet Uveitis. Purpose: Visual prognosis was evaluated in Korean Behcet uveitis patients....	19th July, 2008	Siloam Eye Hospital , Institute of Vision Research, Yonsei University	Ophthalmologica. 2008 Jul 21;222(5):344-350. DOI Direct Link
Brucellosis and uveitis. A 30-year-old-lady, (Case 1) was found to have brucella uveitis in her...	11th July, 2008	Department of Infectious Diseases, Yuzuncu Yil University, Faculty of	Ann Ophthalmol (Skokie). 2008 Spring;40(1):48-50.
Ocular inflammatory signs observed in a cohort of Spanish patients with Behcet disease and ocular inflammation. Purpose. To study the clinical characteristics of a cohort of Spanish...	9th July, 2008	Department of Ophthalmology, Hospital Clinico universitario San	Eur J Ophthalmol. 2008 Jul-Aug;18(4):563-6.
Vogt-koyanagi-harada syndrome. PURPOSE: Vogt-Koyanagi-Harada syndrome is a bilateral, chronic, diffuse...	5th July, 2008	State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun	Curr Eye Res. 2008 Jul;33(7):517-23. DOI Direct Link
An atypical case of Whipple's disease: case report and review of the literature. We report the case of a 57-year-old man, presenting with bilateral...	26th June, 2008	Department of General Internal Medicine, Hopital Erasme, Universite libre	Acta Clin Belg. 2008 Mar-Apr;63(2):107-11.
→View more research publications.

Panuveitis Clinical Trials:
A Study of LX211 in Clinically Quiescent Non-Infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis	Uveitis, Posterior;   Uveitis, Intermediate;   Panuveitis

Panuveitis Patents:
US Patent No.	Title
7339065	Design and synthesis of optimized ligands for PPAR
5597567	Blocking cell adhesion molecules and treating animals with ocular inflammation
5773019	Implantable controlled release device to deliver drugs directly to an internal portion of the body
5902790	Pharmaceutical angiostatic dipeptide compositions and method of use thereof
6001386	Implantable controlled release device to deliver drugs directly to an internal portion of the body
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Panuveitis scientists - we have details of around 54 individuals working on Panuveitis .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.